Share

October 2017; 7 (5) Case

Persistent focal enhancement of the cisternal segment of oculomotor nerve in ophthalmoplegic migraine

Ihtesham A. Qureshi, Gustavo J. Rodriguez, Salvador Cruz-Flores, Alberto Maud
First published October 12, 2016, DOI: https://doi.org/10.1212/CPJ.0000000000000303
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
97

Share

Article Information

vol. 7 no. 5 381-383
DOI: 
https://doi.org/10.1212/CPJ.0000000000000303
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received May 17, 2016
  • Accepted August 4, 2016
  • First Published October 12, 2016.

Article Versions

Copyright & Usage: 
© 2016 American Academy of Neurology

Author Disclosures

    1. Ihtesham A. Qureshi, MD,
    2. Gustavo J. Rodriguez, MD,
    3. Salvador Cruz-Flores, MD and
    4. Alberto Maud, MD
  1. Ihtesham A. Qureshi, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Gustavo J. Rodriguez, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. World Journal of Radiology. Associate Editor. 2013-present Journal of Neurology and Stroke. Associate Editor. 2013- present Symbiosis Journal of Neurology. Associate Editor. 2013- present

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Salvador Cruz-Flores, MD and
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. AHA:funding for travel AAN: funding for travel

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Lilly CEC member SUnovion CEC member Quintiles CEC member Duke University CEC member

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. SOCRATES study Astra Zeneca

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Alberto Maud, MD
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Neurology Department, Texas Tech University of Health Sciences Center, El Paso.
  1. Correspondence to:
    drqureshi786{at}hotmail.com
View Full Text

Article usage

Article usage: October 2016 to April 2022

AbstractFullPdfSource
Oct 201610306Highwire
Nov 201615104Highwire
Dec 20162401Highwire
Jan 20172800Highwire
Feb 20171600Highwire
Mar 20172000Highwire
Apr 20171900Highwire
May 20171300Highwire
Jun 20171201Highwire
Jul 20171501Highwire
Aug 20172900Highwire
Sep 20171201Highwire
Oct 20172641426Highwire
Nov 20176941621Highwire
Dec 201719397Highwire
Jan 20187242Highwire
Feb 20185823Highwire
Mar 20185950Highwire
Apr 20188711Highwire
May 20188902Highwire
Jun 20185311Highwire
Jul 20185400Highwire
Aug 20188622Highwire
Sep 20187612Highwire
Oct 20185912Highwire
Nov 20185520Highwire
Dec 20184600Highwire
Jan 20193410Highwire
Feb 201933350Highwire
Mar 20195300Highwire
Apr 20194600Highwire
May 20194410Highwire
Jun 20192671Highwire
Jul 20194020Highwire
Aug 20192810Highwire
Sep 20191300Highwire
Oct 20191913Highwire
Nov 20191600Highwire
Dec 20193022Highwire
Jan 20202200Highwire
Feb 20201501Highwire
Mar 20201300Highwire
Apr 20201500Highwire
May 20201300Highwire
Jun 2020811Highwire
Jul 2020700Highwire
Aug 2020501Highwire
Sep 20202800Highwire
Oct 20201510Highwire
Nov 20201700Highwire
Dec 20202500Highwire
Jan 2021700Highwire
Feb 20211000Highwire
Mar 20213212Highwire
Apr 20211700Highwire
May 20211600Highwire
Jun 20212202Highwire
Jul 20211940Highwire
Aug 20211910Highwire
Sep 20212010Highwire
Oct 20212300Highwire
Nov 20211131Highwire
Dec 20211300Highwire
Jan 20221720Highwire
Feb 20221600Highwire
Mar 20221700Highwire
Apr 20221600Highwire

Cited By...

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me